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Abstract: Dengue virus (DENV) is the most important mosquito-borne viral pathogen of humans,
comprising four serotypes (DENV-1 to -4) with a myriad of genotypes and strains. The kinetics of
DENV replication within the mosquito following ingestion of a blood meal influence the pathogen’s
ability to reach the salivary glands and thus the transmission potential. The influence of DENV serotype
and strain diversity on virus kinetics in the two main vector species, Aedes aegypti and Ae. albopictus,
has been poorly characterized. We tested whether DENV replication kinetics vary systematically
among serotypes and strains, using Australian strains of the two vectors. Mosquitoes were blood fed
with two strains per serotype, and sampled at 3, 6, 10 and 14-days post-exposure. Virus infection
in mosquito bodies, and dissemination of virus to legs and wings, was detected using qRT-PCR.
For both vectors, we found significant differences among serotypes in proportions of mosquitoes
infected, with higher numbers for DENV-1 and -2 versus other serotypes. Consistent with this,
we observed that DENV-1 and -2 generally replicated to higher RNA levels than other serotypes,
particularly at earlier time points. There were no significant differences in either speed of infection or
dissemination between the mosquito species. Our results suggest that DENV diversity may have
important epidemiological consequences by influencing virus kinetics in mosquito vectors.
Keywords: dengue viruses (DENV); Aedes aegypti; Aedes albopictus; arbovirus; flavivirus; vector
competence; virus kinetics; genetic diversity
1. Introduction
Dengue virus (DENV) is one of the most important arthropod-borne viruses affecting humans [1].
It is a positive-sense RNA virus and member of the Flavivirus genus, comprising four antigenically
distinct serotypes with multiple genotypes and strains within these. Dengue outbreaks in Australia
predate the 20th century [2], but the past two decades have seen an increasing number of outbreaks
related to increased international air travel and the consequent importation of viruses with travellers
returning to Australia from endemic countries [3–5]. Local virus transmission occurs in central and
North Queensland, where there is an established presence of Aedes aegypti, the primary vector of DENV
in Australia [5,6]. The increasing number and frequency of DENV importations heightens the chances
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of local human populations being exposed to multiple serotypes of DENV and the risk of severe
disease [7]. Aedes albopictus is a highly invasive species with an expanding worldwide range [8], and is
also a competent vector of DENV and other arboviruses [9,10]. It thrives in both temperate and tropical
climates [11]. In the Australian context, modelling has shown that all of mainland Australia’s coastal
regions would provide suitable habitat for Ae. albopictus should it invade [12]. If this were accompanied
by an expanding geographic distribution of DENV, seasonal epidemics in urban centres like Brisbane
or Perth would result in major public health burdens [13]. Populations of Ae. albopictus have already
become established in the Torres Strait between mainland Australia and Papua New Guinea, most
likely due to human maritime traffic from Indonesia [12,14]. The species has been intercepted at
Australia’s mainland air and seaports [15] and was implicated in a 2016 dengue outbreak in the Torres
Strait [16].
The first dengue vaccine Dengvaxia® is licensed in some countries but, due to adverse safety
events [17], the vaccine is recommended only for persons having a prior history of dengue infection,
who are between 9 and 45/60 years and live in a dengue endemic region [18]. Without a universally
available vaccine, efforts to prevent dengue continue to rely on mosquito control strategies, which can
include the use of physical barriers, chemical insecticides and biocontrol [19,20]. Many of these efforts
have been ineffective at times, due, in part, to an incomplete understanding of the factors that regulate
DENV transmission by mosquitoes.
Mosquito populations from different geographic locations vary in their susceptibility to infection
with, as well as the ability to transmit, different strains of DENV [21,22]. Variability among DENV
serotypes and lineages within genotypes has been associated with differences in the extrinsic incubation
period (EIP) [23–25], the time it takes an arbovirus to disseminate in the mosquito, from the ingestion
of an infected blood meal to when the virus can be detected in saliva. Previous studies have reported
variation in DENV EIPs of between 2 and 15 days [26]. For example, differences in the dissemination
of different strains of DENV-2 have been observed [27] and a Southeast Asian genotype of DENV-2
has been shown to have shorter EIP than an American strain which it displaced [28]. However, most
vector competence studies have focused on the susceptibility of mosquito populations to infection with
individual strains or small collections of strains that represent only a subset of the genetic diversity of the
dengue viruses [29,30]. This reduces the accuracy of comparison of virus replication kinetics between
serotypes as virus replication is highly dependent on experimental factors. Furthermore, investigations
are typically restricted to assessments of virus kinetics within a single mosquito species [31]. Here,
we systematically tested whether variation in DENV serotypes and strains results in differences in
infection and dissemination kinetics by simultaneously testing representative strains from all four
dengue serotypes in both Ae. aegypti and Ae. albopictus.
2. Results
We quantified the replication dynamics of eight genetically diverse strains of DENV representing
all four serotypes (two strains/serotype), that had been isolated from outbreaks in South East Asia and
the Pacific over a 25-year period (Table 1). We orally exposed mosquitoes from Australian populations
of Ae. aegypti and Ae. albopictus to 107 pfu/mL of DENV in sheep blood. The overall proportions of
Ae. aegypti (63%) and Ae. albopictus (57%) that engorged on the DENV infected blood meals were similar.
Mosquitoes were sampled at 3, 6, 10 and 14 d post exposure (dpe) and tested for DENV
infection in bodies and dissemination to legs and wings (hereafter referred to as legs/wings) using
quantitative Reverse Transcriptase—Polymerase Chain Reaction (qRT-PCR). Both species of mosquito
were susceptible to infection with all DENV strains tested.
Pathogens 2020, 9, 668 3 of 14
Table 1. Strains of DENV used in vector competence experiments.
Serotype Strain Country of Origin Date of Isolation
DENV-1 NC483 New Caledonia 2008
ET243 * Timor-Leste 2013
DENV-2 VN130604 Vietnam 2002
55763 Timor-Leste 1985
DENV-3 ET-3 * Timor-Leste 2000
DENV-4
31298 Cook Islands 1988
MY1261 Myanmar 2000
NC-39 New Caledonia 2009
* Strains were isolated in Australia from patients infected in Timor-Leste.
The proportion of Ae. aegypti bodies with a detectable DENV infection increased over time for
each strain (Table 2). Infection rate patterns for strains within serotypes were broadly similar and
differed between DENV serotypes. DENV serotypes 1 and 2 strains infected the highest proportion of
mosquitoes (range 35–70% at 14 dpe) whereas strains from serotypes 3 and 4 infected a maximum of
30% of mosquitoes by 14 dpe. DENV-2 strain NC-483 infected the highest proportion of mosquitoes
of any strain (70%). Dissemination of DENV to Ae. aegypti mosquito leg and wing tissue was first
detected at 6 dpe for all serotypes (Table 2). The proportion of mosquitoes with virus in leg and wing
tissues gradually increased over time, reaching a maximum of 20–40% of mosquitoes for DENV-1 and
DENV-2 strains, and 10–20% for DENV-3 and DENV-4 strains. Given the similarities between strains
from each serotype, the data were pooled for each serotype and the effect of serotype on the proportion
of mosquitoes infected at different time points was tested (Supplemental Table S1). Serotypes differed
significantly in their ability to lead to a detectable infection in mosquitoes at 6 and 10 dpe (p < 0.05,
Fisher’s exact test). When leg and wing infection rates were pooled for different strains within each
dengue serotype, serotype significantly affected the proportion of mosquitoes with a leg and wing
infection at 10 dpe but not at the other time points (Supplemental Table S1).
The levels of DENV RNA accumulation in Ae. aegypti bodies and legs/wings harvested after the
four incubation periods were quantified by qRT-PCR. Virus loads in mosquito bodies and legs/wings
samples, defined here as the log10 number of DENV copies per sample, were determined for individual
Ae. aegypti mosquitoes according to virus strain and time point (Figure 1). The highest mean (±SD)
virus load in bodies was from DENV-3 (ET-3), reaching 6.10 ± 0.44 log10 DENV copies at 10 dpe
(Figure 1a). The number of virus copies detected from Ae. aegypti leg and wing tissue generally
increased or remained stable from 6 to 14 dpe and reached between 2.3 to 7 log10 genome copies
across all strains at 14 dpe (Figure 1b). The highest mean (±SD) virus load in legs and wings was from
DENV-2 55763, which reached 4.62 ± 0.87 log10 RNA copies/mosquito at 14 dpe.
Similar to Ae. aegypti, the proportion of Ae. albopictus bodies with a detectable dengue infection
increased over time and infection patterns differed more greatly between dengue serotypes than for
strains within each serotype (Table 2). Higher infection rates were again observed from DENV-1 and
DENV-2 strains (20–55% mosquitoes infected) compared to DENV-3 and DENV-4 strains (10–45%
mosquitoes infected). The data were pooled for each serotype and significant differences in the
proportion of mosquito bodies with a detectable dengue infection were observed between serotypes at
6, 10 and 14 dpe (Supplemental Table S2). Disseminated infections were first detected from Ae. albopictus
leg and wing tissue between 6–10 d for DENV-1 and DENV-2 strains and between 6–14 d for DENV-3
and DENV-4 strains (Table 2). The proportion of mosquitoes with detectable infection in Ae. aegypti
leg and wing tissue generally increased over time to reach a maximum of between 10 and 30% of
mosquitoes for DENV-1 and DENV-2 strains and between 5% and 20% for DENV-3 and DENV-4
(Table 2). The proportion of mosquitoes with detectable infection in leg and wing tissue differed
significantly between dengue serotypes at 6 and 10 dpe but not at the other time points (Supplemental
Table S2).
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Figure 1. Growth kinetics of dengue virus strains from all four serotypes within Ae. aegypti mosquitoes.
Virus loads in (a) bodies and (b) legs and wings. Points show the number of virus copies in individual
samples. Lines indicate means. nt, not tested (mosquitoes infected with DENV-1 ET-243 did not survive
to 14 dpe). LOD, limit of detection.
The mean number of dengue genome copies in Ae. albopictus bodies generally increased from
0–10 dpe before stabilizing or decreasing to 14 dpe (Figure 2). The highest mean (±SD) virus loads
were observed from DENV-2 VN130604 and DENV-1 ET243 (5.91 ± 0.36 log10 and 5.90 ± 0.60 log10
RNA copies/mosquito, respectively, at 10 dpe). The mean number of dengue genome copies in leg
and wing tissue generally remained stable between 6 and 14 d, however there was an increasing trend
for DENV-2. The highest mean (±SD) DENV titre in Ae. albopictus legs and wings was observed from
DENV-1 (NC-483) at 14 dpe (4.27 ± 0.41 log10 RNA copies/mosquito).Pathogens 2020, 9, x FOR PEER REVIEW 6 of 14 
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Table 2. Infection rates among Aedes aegypti and Aedes albopictus mosquitoes following feeding on eight strains of dengue from four serotypes. dpe, days post exposure.
nt, not tested. Ae. aegypti mosquitoes infected with DENV-1 (ET-483) did not survive to 14 dpe.
Mosquito Infection Rate (n Tested) at Various Days Post Exposure (dpe) to Dengue Virus
3 dpe 6 dpe 10 dpe 14 dpe
Mosquito Serotype Strain Bodies Legs/Wings Bodies Legs/Wings Bodies Legs/Wings Bodies Legs/Wings
Ae. aegypti DENV-1 NC-483 15 (20) 0 (20) 40 (20) 25 (20) 50 (20) 25 (20) 70 (20) 25 (20)
ET-243 0 (20) 0 (20) 5 (20) 0 (20) 30 (20) 25 (20) nt nt
DENV-2 VN-130604 5 (20) 0 (20) 10 (20) 5 (20) 45 (20) 40 (20) 35 (20) 20 (20)
55763 5 (20) 0 (20) 30 (20) 10 (20) 30 (20) 20 (20) 40 (20) 25 (20)
DENV-3 31298 5 (20) 0 (20) 5 (20) 5 (20) 10 (20) 5 (20) 25 (20) 20 (20)
ET-3 0 (20) 0 (20) 0 (20) 0 (20) 20 (20) 5 (20) 25 (20) 10 (20)
DENV-4 NC-39 0 (20) 0 (20) 5 (20) 0 (20) 10 (20) 5 (20) 30 (20) 10 (20)
MY-1261 5 (20) 0 (20) 15 (20) 10 (20) 25 (20) 20 (20) 25 (20) 20 (20)
Ae. albopictus DENV-1 NC-483 0 (20) 0 (20) 40 (20) 20 (20) 40 (20) 20 (20) 55 (20) 30 (20)
ET-243 0 (20) 0 (20) 0 (20) 0 (20) 15 (20) 10 (20) 25 (20) 15 (20)
DENV-2 VN-130604 5 (20) 0 (20) 10 (20) 0 (20) 35 (20) 30 (20) 40 (20) 30 (20)
55763 5 (20) 0 (20) 15 (20) 10 (20) 25 (20) 10 (20) 20 (20) 10 (20)
DENV-3 31298 0 (20) 0 (20) 0 (20) 0 (20) 10 (20) 10 (20) 45 (20) 20 (20)
ET-3 0 (20) 0 (20) 0 (20) 0 (20) 10 (20) 5 (20) 40 (20) 10 (20)
DENV-4 NC-39 0 (20) 0 (20) 0 (20) 0 (20) 0 (20) 0 (20) 10 (20) 5 (20)
MY-1261 10 (20) 0 (20) 10 (20) 10 (20) 15 (20) 10 (20) 15 (20) 10 (20)
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3. Effects of Mosquito Species, Virus Strain and Incubation Time on DENV Loads
Given the strong similarities in the infection kinetics of the DENV strains in both Ae. aegypti
(Figure 1) and Ae. albopictus (Figure 2), we tested the significance of the main effects of mosquito species,
virus strain and incubation time using a general linear model (GLM). The main effects of incubation
time and virus strain significantly affected genome levels for body and legs/wings samples (Table 3).
However, the main effect of mosquito species (Ae. aegypti or Ae. albopictus) was not significant for either
tissue type.
Table 3. Main effects of virus strain, incubation period and mosquito species on the number of DENV
genome copies in mosquito bodies and legs/wings determined using a general linear model (GLM).
Data excludes samples in which no DENV copies were detected. The main effects that are significant at
p-value < 0.05 are bolded. df, degrees of freedom. F, F statistic.
Effect
Body
(Error df = 37)
Legs/Wings
(Error df = 26)
df F p-Value † df F p-Value †
Incubation period 3 4.09 0.013 2 * 19.66 <0.001
Mosquito Species 1 0.48 0.49 1 2.96 0.097
Virus strain 7 4.12 0.002 7 4.77 0.001
* Legs/wings sampled at 3 dpe were negative for DENV. † p-value based on the F-statistic with degrees of freedom
corresponding to the effect and the error term.
As the overall effect of mosquito species was not significant, data for both species were pooled
and the within-treatment effects of virus strain and incubation time were compared for bodies and
legs/wings by pairwise testing using Tukey’s method. DENV-1 and DENV-2 reached significantly
higher virus genome copy numbers in mosquito bodies than the DENV-4 strain NC-39s (Tukey’s
multiple pairwise comparisons; Figure 3). DENV-1 strains and DENV-2 (55763) reached higher genome
copy numbers in mosquito legs and wings than mosquitoes infected with DENV-4 NC39, while all
other strains reached intermediate titres in legs/wings. Similarly, over all strains and mosquito species,
DENV virus titres in mosquito bodies increased significantly from 3 dpe to 10 dpe (Tukey’s multiple
pairwise comparisons; Figure 3) before stabilising. In legs and wings, viral RNA was not detected in
any mosquito at 3 dpe, however there were significant increases in virus genome copy numbers over
successive time points from 6 to 14 dpe.
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4. Discussion
We have identified substantial differences in the kinetics of virus infection between dengue
serotypes and strains within the two major mosquito vector species, Ae. aegypti and Ae. albopictus.
Virus infection kinetics were generally more similar between strains within a serotype than strains from
other serotypes. We observed that DENV-1 and -2 infected the largest proportion of mosquitoes and
generally produced the highest titres within mosquito tissue, consistent with previous observations
from studies utilizing independent virus strains [32] and genetically different mosquito populations [33].
These findings support a hypothesis that the higher infectivity and increased virulence of DENV-1
and DENV-2 in Aedes mosquito vectors have contributed to the global dominance and higher disease
burden caused by DENV-1 and -2 [34]. However, some within serotype variation was observed.
For example, while DENV-1 NC483 out-performed most of the other DENV strains in both infection
and dissemination, DENV-1 ET243 disseminated at a relatively slower rate, especially in Ae. albopictus.
Furthermore, across all virus serotypes and strains, variation in virus load between mosquito species
was non-significant. This challenges the reputation of Ae. albopictus as a secondary vector of dengue
behind Ae. aegypti. Data on transmission rates are required to confirm these findings.
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Most previous studies of virus replication dynamics and EIP for DENV have infected a single
species of mosquito with individual or small collections of virus strains, making it difficult to compare
virus replication kinetics between DENV serotypes [23,35,36]. As such, there is limited data available
on the influence of DENV serotype or strain on the kinetics of DENV infection in mosquitoes [26].
Here we simultaneously evaluated multiple strains of the four serotypes of DENV. We show that both
serotype and strain differences help determine the speed of dissemination of dengue virus within
mosquitoes. In general, DENV-2 VN130604 achieved peak infection rate in both mosquito species
at day 10 dpe while DENV-3 ET3 achieved peak infection and dissemination rates at 14 days post
infection. This may be due to differences in virus replication kinetics that reflect intrinsic differences
between virus serotypes.
Differences in the kinetics of infection in mosquitoes potentially affect mosquito vector competence
and progression of dengue outbreaks [31]. Although it is well established that other factors, including
temperature [37–39] and mosquito genes [40] influence virus replication dynamics, the impact of
variation in serotypes and strains is often ignored in vector competence models [41]. Virus strain
diversity contributes to heterogeneity in DENV transmission dynamics and while it may be impossible
to evaluate individual strain attributes, an attempt to capture the evolutionary and epidemiological
potential of different strains should be made in future dengue control strategies and models.
Aedes albopictus is considered to play a secondary role in transmission of DENV where Ae. aegypti
and Ae. albopictus co-exist. Previous studies found that dissemination of dengue virus took longer in
Ae. albopictus than in Ae. aegypti [33,42], however comparisons were not significant in our analyses
(data not shown). Dissemination rates at 14 days post exposure varied from 10 to 50% in Ae. aegypti
and from 5 to 45% in Ae. albopictus, which indicated that both species may become competent for
transmission at a similar rate. Furthermore, we showed that the dengue strains reached equivalent
titres in both vector species. Ae. albopictus has been implicated in DENV transmission in the Torres
Strait [16] and should it become established on the Australian mainland, it would present a serious
risk of DENV transmission in any urban centres that receive large numbers of viraemic visitors or
returning residents from dengue endemic countries [12]. Key to gauging that risk is an understanding
of the competence of Ae. albopictus for commonly circulating strains of DENV. Our findings, together
with greater potential for range expansion of Ae. albopictus in Australia necessitate that Ae. albopictus be
regarded as posing at least an equivalent level of risk of dengue transmission to Ae. aegypti in Australia.
A limitation of our study is that we did not investigate the appearance of detectable virus in the
saliva of mosquitoes. However, previous evidence indicates that dissemination of DENV to legs and
wings of mosquitoes is generally a reliable indicator of whether mosquitoes are capable of transmitting
DENV [23,43,44], at least for Ae. aegypti. Another feature of this study which may affect how the
outcome is compared to other assessments of mosquito vector competence is the use of qRT-PCR to
quantify virus titre in mosquito tissues rather than a live virus assay such as a plaque assay to detect
infectious virus. However, the detection of virus genomes allowed us to effectively determine the
kinetics of infection such as the time at first detection of virus in different tissues and to measure
relative differences in virus titres between the serotypes. We only tested a single infectious dose of
107 PFU/mL. This dose is within the range of titres observed from human viraemia; however, a range
of infectious doses may have presented a different set of parameter estimates given that infectious
dose is a powerful determinant of DENV infection probability and virus kinetics in Ae. aegypti [45–47].
This study has established that there is significant variation in the interval between the ingestion
of a blood meal and the appearance of detectable virus in the legs and wings of Australian Ae. aegypti
and Ae. albopictus among DENV isolates representing the diversity of serotypes circulating in Southeast
Asia and the Pacific. The heterogeneity in DENV transmission kinetics highlighted here, even
within the same serotype, could potentially affect the timing and magnitude of dengue outbreaks.
Should Ae. albopictus become established on mainland Australia, it is possible this species will be able
to transmit multiple strains of DENV to a similar extent to Ae. aegypti. This work represents the first
parallel evaluation of multiple regionally relevant strains of DENV in regionally relevant populations
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of Ae. aegypti and Ae. albopictus mosquitoes and raises important questions about the epidemiological
implications of strain and serotype diversity in DENV. It also underscores the potential contribution of
Ae. albopictus to DENV transmission in mainland Australia.
5. Materials and Methods
5.1. Viruses
Four strains of DENV were obtained from the WHO Collaborating Centre for Arbovirus Reference
and Research at Queensland University of Technology (QUT) Australia, with additional strains being
generous gifts from Prof Paul Young (The University of Queensland) and Dr Myrielle Dupont-Rouzeyrol
(Institut Pasteur New Caledonia). All viruses had been passaged 3–7 times after isolation from patients.
The viruses were propagated at 27 ◦C in mosquito C6/36 cells following infection at a multiplicity
of infection of 0.1. Supernatants containing infectious virus were harvested at times of peak virus
production; 5 days post infection (p.i.) for DENV-1 (NC-483), DENV-2 (55763), DENV-4 (NC-39)
and DENV-4 (MY1261), at 6 days p.i. for DENV-2 (VN-130604) and DENV-3 (ET-3), and 7 days p.i.
for DENV-1 (ET-243) and DENV-3 (31298). Virus stocks were then concentrated by ultrafiltration in
100 kDa Amicon filters (Merck Millipore, Burlington, MA, USA) according to the manufacturer’s
instructions and aliquoted into sterile 2 mL tubes before freezing at −80 ◦C.
5.2. Mosquitoes
Ae. aegypti and Ae. albopictus mosquitoes used in infection experiments were sourced from established
colonies at QIMR Berghofer Medical Research Institute (QIMR Berghofer). The Ae. albopictus colony
originated from eggs collected on Hammond Island, Torres Strait in June 2014. The Ae. aegypti colony was
established from Wolbachia-free eggs collected from Cairns, Queensland in 2015. Both mosquito colonies
were established and maintained in the QIMR Berghofer insectary at 27 (±1) ◦C and 75 (±5)% relative
humidity (RH), with a photoperiod of 12 h:12 h light:dark (L:D) cycles.
5.3. Immunofocus Assay
Titres of infectious virus were quantified by performing an immuno-focus assay based on the
immuno-detection of infectious foci developing in African green monkey kidney epithelial cell (Vero:
ATCC) monolayers. Once confluent, cells were inoculated with ten-fold serial dilutions of virus in
Dulbecco’s Modified Eagle Medium D-glucose (1 g/L) and sodium pyruvate/L-Glutamine (100 ng/L)
(Life Technologies Australia, Mulgrave, Australia). The virus was allowed to adsorb for 2 h at 37 ◦C,
then cells were overlayed with 8% w/v carboxy-methyl cellulose (Sigma-Aldrich, Castle Hill, Australia)
in Medium 199 (Sigma-Aldrich). Plates were incubated at 37 ◦C and 5% v/v CO2/air for 5–7 days. At the
conclusion of the incubation period, the overlay was discarded, and the cell monolayers were washed
in PBS, dried and fixed with ice-cold (1:1 (v/v) acetone-methanol (200 µL/well) at room temperature
for 5 min. The fixative then was aspirated, and the plates dried at room temperature again for 1 h.
Plates were stored inverted for at least 8 h at 4 ◦C before staining. Non-specific binding of antibodies
to the cell monolayer was blocked by the addition of 200 µL of 5% w/v skim milk powder in PBS for
1 h at 37 ◦C. DENV infected cells were detected by the addition of 200 µL anti-flavivirus envelope
reactive monoclonal antibody 4G2 (TropBio, Cairns, Australia) [48] diluted 1:1000 in 5% (w/v) skim
milk powder in 1× Phosphate Buffered Saline (PBS) to each well for 1 h at 37 ◦C. After six washes
with PBS, horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (Invitrogen, Carlsbad, CA,
USA) diluted 1:2000 v/v in 5% w/v SMP/PBS was added to each cell monolayer for 1 h at 37 ◦C.
The antibody solution then was discarded, the cell monolayers washed six times with PBS and 200 µL
of substrate/chromogen (urea hydrogen peroxide/3,3′Diaminobenzidine, Sigma-Aldrich) added and
incubated in the dark for 15 min. DENV positive foci or plaques were counted and stock concentration
of each virus was quantified as plaque forming units (PFU) per mL.
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5.4. Mosquito DENV Challenge Experiments
Mosquito eggs were hatched by submerging in aged de-chlorinated tap water (Ae. aegypti) or rainwater
(Ae. albopictus). Larvae were reared at a density of 250 mosquitoes in 3 L of water in larval development
trays and were provided fish food (Tetramin, Tetra Melle, Germany) ad libitum. Pupae were transferred to
500 mL bowls inside 30 × 30 × 30 cm insect rearing cages (BugDorm, Megaview, Taiwan) where adults
emerged and mated freely. Adults were maintained on 10% w/v sugar water until blood feeding.
Female mosquitoes (5–7 days old) were starved for 12 h and deprived of water for 6 h prior to
being offered a viraemic blood meal for 1 h on a membrane. For each mosquito species, two groups
of approximately 100 mosquitoes each were exposed to one strain of DENV. The membrane feeding
apparatus consisted of a series of glass membrane feeders with inner blood-filled chambers covered
with pig intestinal membrane (sausage casing) and outer chambers connected by pipes circulating water
from a 37 ◦C water bath. The blood meal consisted of 1:1 mix of defibrinated sheep blood (Equicell,
Melbourne, Australia) and virus (~107 PFU/mL). Adenosine Triphosphate (ATP) (Sigma-Aldrich) was
added to the blood mixture to a final concentration of 5 Mm. Sub-samples of the blood meal were
saved at the completion of feeding to determine the titre of infectious virus at the end of the feeding
process. No significant decreases in the titres of virus were observed (data not shown). After 1 h of
feeding, mosquitoes were anaesthetized with CO2 and sorted on a cold table within a Perspex glove
box. Mosquitoes that were not completely engorged were discarded. The engorged mosquitoes for
each mosquito virus combination were transferred to 250 mL plastic cups and held for up to 14 days in
environmental chambers at 27 (±1) ◦C with 12 h-12 h light-dark (L:D) cycles and provided with 10%
w/v sugar water ad libitum.
For each mosquito-virus combination, 20 mosquitoes were harvested at each of four time points
(3, 6, 10 and 14 days) post blood feeding by anaesthetizing the insects with CO2 and then with ice
before removing legs and wings. The bodies were stored separately from the legs/wings in microtubes
and preserved at −80 ◦C until further testing.
5.5. Detection of Dengue Virus in Mosquito Tissue by qRT-PCR
Mosquito tissue samples were thawed on ice and total RNA isolated as previously described [49].
Briefly, each sample was homogenized with 100-µL extraction buffer (10 mM Tris pH 8.2, 1 mM
EDTA, 50 mM NaCl) and 60 µL proteinase K (15 mg/mL Bioline) in a mini-beadbeater (Biospec,
Bartlesville, OK, USA) for 1.5 min and then incubated in a heat block for 5 min at 56 ◦C. The sample
then was heated at 98 ◦C for 5 min (to inactivate proteinase K). One-step qRT-PCR was carried out in
384-well Hard-Shell® thin-wall plates (Bio-Rad, Gladesville, Australia) with the CFX384™ real-time
PCR detection system (Bio-Rad). The reaction mix was prepared using Taqman® Fast Virus One-Step
RT-PCR Master Mix Reagents (Applied Biosystems, Thermo Fisher Scientific, Brisbane, Australia),
following the manufacturer’s instructions. Each sample was assayed in a 10 µL reaction volume
consisting of 2.5 µL of Taqman® Fast Virus One-Step mix, 3 µL of total RNA extract and 400 nM each
of the forward and reverse primers and 250 nM of probe labelled with FAM and BHQ-1 at the 5′
and 3′ ends respectively. Reverse transcription (RT) was performed at 50 ◦C for 3 min, followed by
inactivation and denaturation of RNA-DNA hybrids at 95 ◦C for 20 s. This was followed by 45 cycles
of 95 ◦C for 10 s, 60 ◦C for 30 s and 72 ◦C for 1 s. A plasmid containing the target DENV genome
sequence (synthesized at Genscript, Piscataway, NJ, USA), serially diluted to known concentrations,
was used to produce DNA standards. Ten-fold dilutions (107 to 101 DNA copies/µL) of the purified
linearized plasmids were tested to generate standard curves and to determine the limit of detection
across qPCR runs.
To determine the threshold cycle (Ct), the threshold level of fluorescence was optimized so that
the standard curve gradient was the theoretical value of −3.30, which indicates 100% PCR efficiency.
Data were accepted if the slope of the standard curve was between −3.0 and −3.6 and with a correlation
coefficient (r2) above 0.95. The limit of detection was 10 genome copies/µL. All samples were analysed
in triplicate with each analysis including positive and negative controls, non-template control (NTC)
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and a serially diluted standard curve of the plasmid standard (107 to 101 copies/µL). Samples with
calculated DNA copy number values on or above the limit of detection were scored as “positive”
indicating the presence of DENV.
5.6. Statistical Analysis
Infection was inferred to have occurred if virus was detected in the body. Dissemination was
inferred to have occurred if the virus was detected in legs/wings. The infection rate was calculated as
the number of infected mosquitoes divided by the number of mosquitoes engorged after the bloodmeal.
The dissemination rate was calculated as the number of mosquitoes with legs/wings infected with
DENV divided by the number of mosquitoes engorged after the blood meal. Infection rates were
compared using Fisher’s Exact tests. Duplicate estimates of the DENV RNA loads per sample were
summarised by the geometric mean and then were transformed to be on the log10 scale. For samples
where all technical replicates were negative (i.e., below the limit of detection) were given a value of 1,
so that when analysis on the log10 scale was performed they would have a value of 0. A general linear
model (GLM) was performed on the data. Preliminary analysis indicated similar variances between
mosquitoes within 64 combinations (8 virus strains × 2 mosquito species × 4 time points) per body
site (body or legs/wings), such that the 20 mosquitoes per combination could be pooled together and
summarised as the mean of the log10 RNA data. Preliminary GLMs indicated that the 2-way and
3-way interactions effects were of similar size and could be pooled as an estimate of error to test for
differences between main effects. Hence the GLM tested for differences between levels of the main
effects as a higher order of magnitude than the interactions. Therefore, the following GLM was applied
to the mean of the log10 RNA data and performed separately for the body and legs/wings data.
Log10(RNA) = βDayDay + βSpSpecies + βVVirus
The model had three main effects: Day being a categorical variable of the time point (3, 6, 10 or
14 d). Species being a categorical variable of the two mosquito species (Ae. aegypti and Ae. albopictus),
and Virus being a categorical variable of the eight different dengue virus strains.
Statistical analyses of infectivity and dissemination rates were conducted with STATA version 15,
analyses and graphs of DENV RNA loads were conducted in R (Version 3.6.2) Pairwise comparisons for
Virus type and Day were performed using Tukey’s method in the glht function in R. Graphs prepared
with GraphPad Prism® Version 7.00 (GraphPad Software, La Jolla, CA, USA, 2008).
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